Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Guardant Health is a leading precision oncology company developing innovative liquid biopsy tests. These are used for early cancer detection, diagnosis, and monitoring to optimize cancer therapy through comprehensive genomic testing. Guardant Health is revolutionizing cancer diagnostics for patients worldwide.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Guardant Health is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Guardant Health last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -0.90 USD.
Across its last 3 earnings reports, Guardant Health stock moved by ±11.6% on average the following day. The largest reaction was +27.9% on 10/29/2025; 2 of 3 reactions were positive.
Guardant Health has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.